News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vince & Associates Clinical Research Sponsors the 14th Annual Phase I & IIa Clinical Trials Conference in London



3/18/2013 1:37:41 PM

(Overland Park, KS, March 18, 2013) — Vince & Associates Clinical Research, a premier provider of early phase clinical research services to the global biopharmaceutical industry, recently sponsored and shared valuable information at the Informa Life Sciences 14th Annual Phase I & IIa Clinical Trials Conference held in London, UK. The conference convened more than 160 attendees from pharmaceutical and biotechnology companies and a panel of more than 70 expert speakers. Presentations and panel discussions focused on the failures of past models for early phase development and applying lessons learned to increase trial success.

Lorraine Rusch, Ph.D., vice president of business development at Vince & Associates, chaired the first afternoon stream entitled: “Strategy and Mechanics – Sourcing Models, Sponsor/Vendor Relationships and Patient Recruitment.” Rusch, an industry-tenured scientist and clinical research executive, also provided valuable perspectives as a panelist on the subject of “Examining the Evolving Relationships between Pharmaceutical, Biotech, CROs and Venture Capitalists.”

“I felt honored to share our expertise at the CRO/site level as we continue to support our European clients with respect to new paradigms, partnerships and service models,” said Rusch. “We have had a steady presence in Europe having collaborated with many companies over the past decade. This is what motivated Vince & Associates to sponsor this valuable conference and share our expertise and the story of our evolution.”

Dr. Brad Vince, president and medical director of Vince & Associates, stated, “Vince & Associates is able to support European sponsors with the successful recruitment and execution of complex special population protocols from human abuse liability to adaptive trial design in various Phase I patient populations.”

“Vince & Associates will continue to support the Phase I & IIa Clinical Trials Conference as the major sponsor in 2014,” said Rusch.

About Vince & Associates Clinical Research

Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for more than a decade. The research professionals at Vince & Associates are proud to be recognized in the industry as a “Center of Research Excellence.” Vince & Associates has become a premier clinical research site by utilizing The Physician Research Model® of operation where study teams are led by highly experienced principal investigators intricately involved in all aspects of the clinical trial process.

Vince & Associates operates a state-of-the-art, multimillion-dollar, 90-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. Boutique-hotel-level amenities of the facility include 10 uniquely designed research suites. The 20-inch, bedside, touch-screen entertainment systems allow study volunteers individual access to watch TV and movies, surf the Internet or play a host of games. This new unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short- and long-term clinical trials. From the safety and security of the controlled access unit to the added features of a movie theater and game rooms, no detail has been overlooked.

More Information

Additional background materials pertaining to Vince & Associates Clinical Research are located on the corporate website at http://www.vinceandassociates.com.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES